HIBAR MICROSCIENCES, LLC

Medtech

Lipocalin-modified hemodialysis cartridge (CLEAR) for enhanced removal of protein-bound uremic toxins from blood

Grants
$300K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
1 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Enhanced renal dialysis membrane performance using lipocalin modified substrates$299,999
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1626ANGEL MEDICAL SYSTEMS, INC.——
1627ADVANCED TACTILE IMAGING INC——
1628Evolus, Inc.—$41M
1629HIBAR MICROSCIENCES, LLC——
1630ATOM LIMBS INC.——
1631Medsign International Corp—$250K
1632PLACENTAL ANALYTICS, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.